Lucilactaene, a new cell cycle inhibitor in p53-transfected cancer cells, produced by a Fusarium sp. [2]

Journal of Antibiotics

Volumn 54, Issue 10, 2001, Pages 850-854

  Kakeya, H ^a   Kageyama, S I ^a   Nie, L ^a   Onose, R ^a   Okada, G ^a   Beppu, T ^a   Norbury, C J ^a   Osada, H ^a  

^a RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; DNA; LUCILACTAENE; PROTEIN P53; TRICHOSTATIN A; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA RECOMBINATION; DNA REPAIR; DRUG ACTIVITY; DRUG ISOLATION; DRUG RESISTANCE; DRUG STRUCTURE; FUSARIUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LETTER; MUTATION; NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

FUSARIUM;

EID: 0035167948     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.54.850     Document Type: Letter

References (19)

1. p53, The cellular gatekeeper for growth and division
2. The hallmarks of cancer
3. Genetic instabilities in human cancers
4. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
5. Pharmacological rescue of mutant p53 conformation and function
6. Surfing the p53 network
7. p53 Regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells
8. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells produced by a marine fungus
9. Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors
10. Asymmetric total synthesis of epolactaene
11. Structure elucidation of fusarin C, a mutagen produced by Fusarium moniliforme
12. Biosynthetic studies on the fusarins, metabolites of Fusarium moniliforme
13. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin
14. WAF1 promoter activators from microbial metabolites
15. WAF1, a potential mediator of p53 tumor suppression
16. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinase
17. p21 is a universal inhibitor of cyclin kinases
18. Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine, a nucleotide antibiotic